It has been reported that CSF of ABCG1-/- mice have increased levels of Aβ compared to wild-type mice, but conversely overexpressing ABCG1 does not alter the plaque load, ApoE levels, cholesterol efflux, or cognitive performance in mouse models of AD [133]. This evidence concerns the gene ABCG1 and Alzheimer disease.